Development of Novel antibacterial compounds from subtilosin A

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/519734

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

We aim to overcome a problem that is not being addressed by pharmaceutical companies- i.e., there is an urgent need to develop new classes of antibacterial drugs because of the increasing prevalence of drug resistant bacteria. We will combine genetics, structural biology and chemistry to develop a new class of anti-bacterial drug based on a naturally occurring microbial molecule that is novel in structure and very stable- attributes that make it very different to existing therapeutic approaches.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $490,724.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oral and maxillofacial surgery

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Antibiotics | Antimicrobial resistance | Antimicrobial therapy | Bacterial Pathogens | Drug Design | Food borne infections | Food technology | Microbial infections | Microbiological safety | Structure-Activity Relationships

Related Links